Navigation Links
LifeNet Health and Salvin Dental Specialties Announce Partnership
Date:6/17/2010

VIRGINIA BEACH, Va., June 17 /PRNewswire/ -- Salvin Dental Specialties, Inc. and LifeNet Health are pleased to announce they have signed an exclusive agreement  to advance LifeNet Health's OraGraft™ allograft products in the dental market.

The two companies have been in partnership since 1995. The new agreement builds on the existing relationship between these two companies, which provides LifeNet Health with Salvin Dental's strong, nationally recognized marketing and sales resources, while LifeNet Health's industry-leading reputation and quality allograft products offer a great bone grafting solution for Salvin Dental customers. LifeNet Health will continue to provide educational and research support to the dental community as well as continual support to its current clients through direct distribution.

Salvin Dental was founded in 1981 and is a global leader in the dental implant industry for bone grafting, instrumentation, and equipment. LifeNet Health, founded in 1982, is the country's largest, independent, non-profit, full-service tissue bank.

Under the agreement, Salvin Dental will act as the exclusive U.S. representative for the promotion of OraGraft™ allograft tissue products in the dental industry along with LifeNet Health. Salvin Dental will increase awareness in the dental industry about the availability of allograft products, which may be particularly beneficial for implant bone grafting and sinus lift procedures.

LifeNet Health is responsible for allograft procurement, processing, and distribution. The company utilizes the latest research and processing techniques to assure the highest quality donor screening and follows strict standards regarding donor qualification, tissue processing, and quality system review. Since introducing Allowash® technology in 1995, LifeNet Health has distributed more than 2.4 million allograft products without incidence of disease transmission.  

Bob Salvin, Founder and CEO for Salvin Dental, said, "Because of LifeNet Health's world-class reputation for its stringent quality processes and Salvin Dental's understanding of the bone grafting needs of the dental industry, this partnership benefits the customers we serve."

Rony Thomas, LifeNet Health's President and CEO, stated, "We are committed to working with Salvin Dental to provide LifeNet Health's OraGraft™ allograft to the patients who need them, and we are proud to be a part of the comprehensive Salvin Dental product offering."

Salvin Dental Specialties, Inc. is dedicated to providing innovative products and exceeding customers' expectations for quality, value, and service every time they call. For additional information about Salvin Dental Specialties, Inc., visit www.salvin.com.

LifeNet Health helps save lives and restore health for thousands of patients each year. LifeNet Health is the world's most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies—a leader in the field of regenerative medicine while always honoring the donors and healthcare professionals that allow the healing process.  For additional information about LifeNet Health, visit www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeNet Health Announces First Bio-Implant with New Preservation Technology
2. New Publications Highlight LifeNet Healths Life Saving Work in Neurosurgery
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Tone Deafness Explained, from the Harvard Health Letter
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... the North East region. Côté has 20+ years of experience within the beauty ... Côté worked with an array of high-end cosmetic brands, retail brands and outlets ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight ... online modeling resource for fluorescence microscopists and optical system designers, enabling The Right ... years spanning the globe, SearchLight has become a tremendously popular tool for the ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... deodorant. On the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific ... actually works! , Countless deodorants flood the aisles that contain harmful chemicals that ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product ... oil many times purer and more potent than the market has seen before. Swissx ... Switzerland, as well as a patented chromatography process for extraction, to produce its CBD ...
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
Breaking Medicine News(10 mins):